This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
List/tripsitting: Difference between revisions
Jump to navigation
Jump to search
>Graham m replace therapies with depression treatment header |
>Graham adding distinction of variant and invariant treatments and explanation about why there aren't antidotes listed for stimulants. |
||
| Line 33: | Line 33: | ||
*[[''Wabi-Sabi'']] | *[[''Wabi-Sabi'']] | ||
</li> | </li> | ||
<li class="featured list-item"> | |||
<h4 class="media-heading">Invariant addiction treatment</h4> | |||
</li> | |||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Psychedelic antidotes|Antidotes]]</h4> | <h4 class="media-heading">[[Psychedelic antidotes|Antidotes]]</h4> | ||
| Line 87: | Line 91: | ||
<h4 class="media-heading">[[Dissociative psychological first aid|Psychological first aid]]</h4> | <h4 class="media-heading">[[Dissociative psychological first aid|Psychological first aid]]</h4> | ||
*[[Immersion modifications]] | *[[Immersion modifications]] | ||
</li> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">Invariant short-term depression treatment</h4> | |||
</li> | </li> | ||
</ul> | </ul> | ||
| Line 154: | Line 161: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[GABAergic tripsitting]]</h4> | <h4 class="media-heading">[[GABAergic tripsitting]]</h4> | ||
<h4 class="media-heading">Invariant anxiety treatment</h4> | |||
*[[Anticonvulsants/antiepileptics]]: [[List_of_pharmaceuticals#Anticonvulsants/antiepileptics|Common]] | *[[Anticonvulsants/antiepileptics]]: [[List_of_pharmaceuticals#Anticonvulsants/antiepileptics|Common]] | ||
*[[Flumazenil]] (for ''[[benzodiazepine]] overdose'') | *[[Flumazenil]] (for ''[[benzodiazepine]] overdose'') | ||
| Line 163: | Line 171: | ||
*[[Naloxone]] (for ''[[opioid]] overdose'') | *[[Naloxone]] (for ''[[opioid]] overdose'') | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 177: | Line 181: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | <h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | ||
* Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as [https://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome neuroleptic malignant syndrome.] | |||
</li> | |||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 187: | Line 193: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | <h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | ||
*[[MDMA-AP]] | |||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
Revision as of 04:53, 2 May 2024
Psychedelic tripsitting 
-
Psychological first aid
-
Long-term depression treatment
-
Neuroaesthetics
-
Invariant addiction treatment
-
Antidotes
- Anticonvulsants/antiepileptics: Common
- Antipsychotics: Common
- Anxiolytics: Common
- Hydroxyzine (for paranoia along with antipsychotic mechanisms)
- Serotonin syndrome treatment: Common
Dissociative tripsitting 
-
Psychological first aid
-
Invariant short-term depression treatment
Deliriant tripsitting 
-
Antidotes
- Physostigmine (for diphenhydramine overdose)
Cannabinoid tripsitting 
-
Psychological first aid
-
Humor varieties
-
Antidotes
- CBD (non-inhalant ROA): Firstly: Vaped or smoked CBD heated to 250-300 C will partially be converted to THC.[1] Thus it's inconvenient to smoke or vape CBD to relieve a THC toxicity. Secondly: 50 times more CBD than THC is needed to reduce acute effects of THC,[2] which makes it practically impossible to administer proper dosage by inhalation. Also, the quantity of CBD converted into THC will increase a lot with the required ratio, and excessive harshness in the lungs may escalate a bad trip.
Miscellaneous hallucinogen tripsitting 
Depressant tripsitting 
-
Antidotes
- Atropine (for nerve agent poisoning)
- N-acetylcysteine (for acetaminophen overdose)
-
GABAergic tripsitting
Invariant anxiety treatment
- Anticonvulsants/antiepileptics: Common
- Flumazenil (for benzodiazepine overdose)
-
Opioid tripsitting
Stimulant tripsitting 
-
Dealing with stimulant psychosis
- Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as neuroleptic malignant syndrome.
- ↑ Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). "CBD, a precursor of THC in e-cigarettes". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMID 33903673.
- ↑ Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). "Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.